Congress reauthorizes Ryan White Care Act - funding for HIV/AIDS

The New York Times: "The House on Wednesday overwhelmingly passed legislation allocating billions of dollars in federal money for the treatment of HIV and AIDS.  By a vote of 408-9, the House reauthorized the Ryan White Care Act, first enacted in 1990 and named for the Indiana teenager who died of AIDS. The Senate has already passed the bill by unanimous consent."

"The bill ... approves an additional four years of funding for the program, which is administered by the Department of Health and Human Services to about 500,000 lower-income people each year. It allocates $2.55 billion for fiscal year 2010, with that figure rising to $2.95 billion by the 2013 fiscal year" (Becker, 10/21).

Dow Jones Newswires: "Both the Senate and House bills state the federal government must establish a goal of testing 5 million patients annually for HIV and AIDS. Federal health agencies will have to report to Congress to detail whether they met the goal" (Favole, 10/21).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

  1. Victor Payne Victor Payne United States says:

    Let me thank all who worked to assure funding in fight against HIV/AIDS in US. Already, PEPFAR's $63Bn is doing wonders. Why is the funding for US citiznes so small? And with all the technological advancement, why is US not eliminating new infection rate domestically? I will like to know how is US measuring progress to defeat HIV/AIDS?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights into the mechanisms of efavirenz-induced neurotoxicity